News
Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.
Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.
A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...
Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.
An animal tranquilizer is the new drug on the street in. Medetomidine is not approved for human use, but doctors say people ...
The FDA is phasing out animal testing and moving to more human-relevant methods. This was announced as one of Marty Makary’s ...
Turbine’s virtual lab enables in silico experimentation using a vast library of cell models, patient-derived samples and virtual patients. By computationally predicting therapy effects, drug ...
Blocking the PROX1 protein allowed KAIST researchers to regenerate damaged retinas and restore vision in mice. Vision is one ...
Andrei Georgescu of Vivodyne discusses key advantages of its humanized drug testing platform and the impact of the FDA’s ...
The FDA is shifting towards a more human-relevant approach to drug testing, encouraging the use of New Approach Methodologies such as laboratory-grown human cell models, organ-on-a-chip systems, ...
The Physicians Committee for Responsible Medicine filed complaints with Oregon Health & Science University, the United States ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results